Company details
Aignostics
Berlin AI company building digital-pathology tools and models for biomedical research and precision medicine.
Alt-Moabit 73/73A, 10555 Berlin
Ghost roles: 1 of 2 open
Stability signals
- CEO
- Viktor Matyas
- Founders
- Viktor Matyas, Maximilian Alber, Frederick Klauschen, Klaus-Robert Müller
- Total raised
- €19M
- Recent rounds
- September 2022 · €14M · Series A
- August 2020 · €5M · Seed
- Founders' prior
companies - Unknown
- Google rating
- 4.0 ★ · 8 reviewsAlt-Moabit 73/73a, 10555 Berlin, Germany
- Recent evidence
Conditional Public Investment Selection · Aignostics was selected to advance to EIC STEP Scale Up investment review in 2026, subject to due diligence and successful negotiations.
Scope: Aignostics Berlin/New York AI pathology business.
Evidence reviewed 2026-10-24. This claim does not establish overall financial stability.
Verified 2026-10-09
At a glance
Open roles
2
activeNew this month
0
New openings
1
opened in the last 90 daysGerman requirement
50%
based on 2 of 2 rolesOpen roles over time
Open roles · 12 months
2open
2025-12 → 2026-11Month-end counts · Nov shows current open roles
2 open roles
- Berlin
- 2